Correlation Between Transcode Therapeutics and IONQ

Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and IONQ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and IONQ into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transcode Therapeutics and IONQ Inc, you can compare the effects of market volatilities on Transcode Therapeutics and IONQ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of IONQ. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and IONQ.

Diversification Opportunities for Transcode Therapeutics and IONQ

-0.9

Correlation Coefficient

Transcode Therapeutics  IONQ

Pay attention - limited upside

The 3 months correlation between Transcode and IONQ is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and IONQ Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IONQ Inc and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with IONQ. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IONQ Inc has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and IONQ go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and IONQ

Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the IONQ. But the stock apears to be less risky and, when comparing its historical volatility, Transcode Therapeutics is 2.72 times less risky than IONQ. The stock trades about -0.05 of its potential returns per unit of risk. The IONQ Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  4,132  in IONQ Inc on October 24, 2024 and sell it today you would lose (243.00) from holding IONQ Inc or give up 5.88% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Transcode Therapeutics  vs.  IONQ Inc

Transcode Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

IONQ Inc

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in IONQ Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, IONQ reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Transcode Therapeutics and IONQ

The main advantage of trading using opposite Transcode Therapeutics and IONQ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, IONQ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IONQ will offset losses from the drop in IONQ's long position.

The idea behind Transcode Therapeutics and IONQ Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.